• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Thermo Fisher Scientific Signs Agreement to Acquire Gatan from Roper Technologies

Share:

July 2, 2018

Thermo Fisher Scientific Inc., the world leader in serving science, and Roper Technologies, Inc., a leading diversified technology company, today announced that they have entered into a definitive agreement under which Thermo Fisher will acquire Gatan, Inc., a wholly owned subsidiary of Roper, for approximately $925 million in cash. Gatan is a leading manufacturer of instrumentation and software used to enhance and extend the operation and performance of electron microscopes.

Gatan’s technologies are used in materials science, electronics and life sciences to enable electron microscopy workflows – from specimen preparation and manipulation to imaging and analysis. These solutions, which are platform agnostic, include filter systems, cameras and proprietary software. With approximately 320 employees globally, Gatan is headquartered in Pleasanton, Calif., and has key manufacturing operations in Warrendale, Penn. The business is expected to generate approximately $150 million in revenue for full year 2018.

Dan Shine, president of Thermo Fisher’s Analytical Instruments business, said, “Gatan has been a trusted supplier of components to the electron microscopy industry for many years, and we look forward to building on its strong reputation. Adding Gatan’s technologies to our leading electron microscopy portfolio will enhance our customer offering by creating an integrated system that seamlessly connects microscope hardware, software and accessories. We look forward to welcoming the Gatan team to Thermo Fisher.”

“Thermo Fisher is the perfect home for Gatan, and the combination of these businesses will be an ideal fit for Gatan’s customers and employees,” said Brian Jellison, Roper’s chairman, president and chief executive officer. “We are grateful to Gatan’s talented employees for their contributions to Roper and wish them continued success with their revolutionary work to enable electron microscopy technology.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The transaction, which is expected to be completed by the end of 2018, is subject to customary closing conditions, including regulatory approvals. The pre-merger waiting period for the transaction under Hart-Scott-Rodino in the U.S. expired June 4, 2018. Upon completion of the transaction, Gatan will become part of Thermo Fisher’s Analytical Instruments Segment.

Date: July 2, 2018

Source: MARKETS INSIDER

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Amalgam RX Acquires Adaptive, Conversational, Artificial Intelligence (AI) AssetsAmalgam RX Acquires Adaptive, Conversational, Artificial Intelligence (AI) Assets
  • Shortage of N95 Masks Top Concern for Hospitals with COVID-19 PatientsShortage of N95 Masks Top Concern for Hospitals with COVID-19 Patients
  • Health Gorilla Launches Pharmacy Data, Powered by DrFirstHealth Gorilla Launches Pharmacy Data, Powered by DrFirst
  • Horizon Therapeutics Augments Rare Disease Portfolio with Viela Bio BuyHorizon Therapeutics Augments Rare Disease Portfolio with Viela Bio Buy
  • Cryotherapy Technology Company Vessi Medical Scores $16.5M and More Digital Health FundingsCryotherapy Technology Company Vessi Medical Scores $16.5M and More Digital Health Fundings
  • Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, LlcVivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, Llc
  • Afya Limited Announces the Acquisition of UniRedentor – Sociedade Universitária RedentorAfya Limited Announces the Acquisition of UniRedentor – Sociedade Universitária Redentor
  • Wright Medical inks $435M takeover of implant firm CartivaWright Medical inks $435M takeover of implant firm Cartiva

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications